Filing Flows › Bolt Biotherapeutics (BOLT) › Q1 2026 › vs Q4 2025
Bolt Biotherapeutics (BOLT) Q1 2026 vs Q4 2025 (quarter over quarter)
Bolt Biotherapeutics's revenue fell $2.5M (-99%) from $2.5M in Q4 2025 to $26K in Q1 2026.
Bolt Biotherapeutics, Q1 2026: revenue $26K (-98% year over year), net loss $7.2M, operating cash flow −$8.0M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $26K | $2.5M | −$2.5M | -99% |
| Other income, net | $357K | $454K | −$97K | -21% |
| Net loss | $7.2M | $6.6M | $613K | +9% |
| Costs & expenses | $7.6M | $9.6M | −$2.0M | -20% |
| Operating costs | $7.6M | $9.6M | −$2.0M | -20% |
| Research & development | $4.8M | $5.0M | −$159K | -3% |
| General & admin | $2.8M | $3.1M | −$319K | -10% |
| Operating cash sources | $8.8M | $8.5M | $319K | +4% |
| Depreciation & amortization | $203K | $255K | −$52K | -20% |
| Share-based compensation | $545K | $1.0M | −$496K | -48% |
| Cash used in operations | $8.0M | $7.2M | $867K | +12% |
| Net loss absorbed | $7.2M | $6.6M | $613K | +9% |
| Working capital & other | $1.5M | $1.8M | −$294K | -16% |
Questions
How much did Bolt Biotherapeutics's revenue grow quarter over quarter in Q1 2026?
Bolt Biotherapeutics's revenue fell $2.5M (-99%) from $2.5M in Q4 2025 to $26K in Q1 2026.